hyaluronic acid (HA) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-hyaluronic acid (HA) antibodies (anti-hyaluronic acid, anti-HA) and diagnostic hapten-carrier conjugates BSA-hyaluronic acid (HA), OVA-hyaluronic acid (HA), KLH-hyaluronic acid (HA) antigens for Liver diseases HA detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-HA-Ag01 | BSA-hyaluronic acid (HA) | 756 |
GMP-SMT-HA-Ag02 | OVA-hyaluronic acid (HA) | 756 |
GMP-SMT-HA-Ab01 | Anti-human hyaluronic acid (HA) mouse monoclonal antibody (mAb) | 1953 |
GMP-SMT-HA-Ab02 | Anti-human hyaluronic acid (HA) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-SMT-HA-Ag01 |
Product Name | BSA-hyaluronic acid (HA) |
Target/Biomarker | hyaluronic acid(HA) |
Expression platform | Synthetic |
Bioactivity validation | hyaluronic acid (HA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HA level test of Liver diseases (NULL) and related syndrome evaluation. |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-hyaluronic acid (HA) / OVA-hyaluronic acid (HA) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-HA-Ag02 |
Product Name | OVA-hyaluronic acid (HA) |
Target/Biomarker | hyaluronic acid(HA) |
Expression platform | Synthetic |
Bioactivity validation | hyaluronic acid (HA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HA level test of Liver diseases (NULL) and related syndrome evaluation. |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-hyaluronic acid (HA) / OVA-hyaluronic acid (HA) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-HA-Ab01 |
Product Name | Anti-human hyaluronic acid (HA) mouse monoclonal antibody (mAb) |
Target/Biomarker | hyaluronic acid(HA) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human hyaluronic acid (HA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other hyaluronic acid (HA) antibodies in HA level test of Liver diseases (NULL) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human hyaluronic acid (HA) monoclonal antibody (mAb) is a monoclonal antibody produced by hybridoma technology. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-HA-Ab02 |
Product Name | Anti-human hyaluronic acid (HA) human monoclonal antibody (mAb) |
Target/Biomarker | hyaluronic acid(HA) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Human hyaluronic acid (HA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other hyaluronic acid (HA) antibodies in HA level test of Liver diseases (NULL) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human hyaluronic acid (HA) monoclonal antibody (mAb) is a monoclonal antibody produced by hybridoma technology. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Hyaluronic acid, also known as hyaluronan, is a clear, gooey substance that is naturally produced by your body. The largest amounts of it are found in your skin, connective tissue and eyes. Its main function is to retain water to keep your tissues well lubricated and moist.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.